56.8 F
New York
Wednesday, November 30, 2022

CATEGORY

Op-Ed

What makes Didi choose New York rather than Hongkong for its IPO?

Jason Lin Hong Kong got benefits after U.S. regulators last year enacted a law to boot Chinese companies off U.S. exchanges unless American regulators are...

Team behind Playboy’s successful go-public deal files for $50M IPO for fourth SPAC

Despite the new SEC guidance and subsequent slowdown in recent weeks, SPACs are still attractive. Industry insiders now view the SPAC market as healthier and more rational as the more seasoned SPAC management teams are pushing ahead.

China cracks down on cryptocurrencies again, but it won’t stop investors from trading

The fresh crackdown may make it harder for individuals to buy cryptocurrencies, and the fears of regulatory crackdown could impact miners' business by making it more difficult for them to exchange cryptocurrencies for yuan, but it won't stop crypto speculation.

3 Key Headwinds for Tesla Investors Should Be Concerned About

Jason Lin Tesla's stock price skyrocketed 740% in 2020, but the stocks seemed to lose power as soon as reaching a record high of $900...

Baosheng Announces to Start Blockchain and Cryptocurrency Business

As bitcoin matures, it’s possible that there might be more public companies who take a similar path to join in bitcoin investment or bitcoin mining business.

Nasdaq Sets First Quarter Record with 275 IPOs

The IPO market remained active in the first quarter of 2021 as it followed the continued momentum seen in the second half of last year.

Universe Pharmaceuticals IPO: The First Chinese Patent Medicine Manufacturer Listed On Nasdaq

Traditional Chinese medicine manufacturer Universe Pharmaceuticals (NASDAQ: UPC) is poised to debut on the Nasdaq Capital Market under the ticker symbol “UPC” on Tuesday, March 23.

Ark’s New Price Target for Tesla: $3,000!

Last year, ARK estimated that in 2024 Tesla’s share price would hit $7,000 per share, or $1,400 adjusted for its five for one stock split. Based on ARK‘s updated research, it now estimates that the price could approach $3,000 in 2025.

Baosheng’s SEC filing: Chinese mobile game company CMGE Owns 7.33% of its stocks

Three months ago, Reuters said ByteDance was in talks to buy into CMGE Technology. Even though the information was refuted by both parties, the Chinese mobile games publisher then started to gain more attention from the public. So why did CMGE Technology invest in Baosheng Media Group this time?

Traditional Chinese Medicine Maker Universe Pharmaceuticals Aims To List Shares On Nasdaq Next Week

In 2021, Chinese companies have held 15 IPOs so far. Four of them are Biotech and pharmaceutical-related companies.Universe Pharmaceuticals would join them, and be the first US-listed Chinese company that is focusing on the traditional Chinese medicine derivatives market.

Latest news